Fulcrum Therapeutics Inc (FULC)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Robert J. Gould
Employees:
26 LANDSDOWNE STREET, CAMBRIDGE, MA 02139
617-651-8851

Fulcrum Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.

Data derived from most recent annual or quarterly report
Market Cap 336.476 Million Shares Outstanding40.637 Million Avg 30-day Volume 847.211 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.7
Price to Revenue37.5136 Debt to Equity0.0122 EBITDA-77.866 Million
Price to Book Value3.3983 Operating Margin-422.9714 Enterprise Value503.292 Million
Current Ratio11.771 EPS Growth0.179 Quick Ratio11.553
1 Yr BETA 0.8221 52-week High/Low 33.1 / 6.85 Profit Margin-421.8911
Operating Cash Flow Growth-46.2641 Altman Z-Score16.5821 Free Cash Flow to Firm -67.379 Million
Earnings Report2022-08-09
View SEC Filings from FULC instead.

View recent insider trading info

Funds Holding FULC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FULC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

99.9 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

99.9 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TOURANGEAU GREG CONTROLLER

  • Officer
22,702 2022-05-06 2

GOULD ROBERT J

  • Director
731,210 2022-04-07 2

STUART BRYAN SEE REMARKS

  • Officer
  • Director
340,000 2022-01-19 2

OLTMANS CURTIS GALE SVP, GENERAL COUNSEL

  • Officer
60,000 2022-01-19 3

THOMSON PETER G. VP FINANCE & ACCOUNTING

  • Officer
40,000 2022-01-19 2

DUNN JUDITH SEE REMARKS

  • Officer
140,890 2022-01-19 1

MORABITO CHRISTOPHER CHIEF MEDICAL OFFICER

  • Officer
59,744 2022-01-19 2

RAJAVELU ESTHER CHIEF FINANCIAL OFFICER

  • Officer
0 2022-01-03 2

BANKS SONJA

  • Director
30,000 2021-12-08 2

LEVIN MARK J

  • Director
  • 10% Owner
4,046,425 2021-11-10 3

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
6,473,794 2021-11-10 2

MOXHAM CHRISTOPHER CHIEF SCIENTIFIC OFFICER

  • Officer
72,501 2021-08-10 1

GERAGHTY JAMES A

  • Director
90,714 2021-06-28 2

DORTON KATINA

  • Director
15,000 2021-06-09 1

HAVILAND KATE

  • Director
15,000 2021-06-09 1

COLLINS JAMES J.

  • Director
15,000 2021-06-09 1

EZEKOWITZ ALAN

  • Director
15,000 2021-06-09 1

WALLACE OWEN B. CHIEF SCIENTIFIC OFFICER

  • Officer
133,438 2020-09-14 0

CADAVID DIEGO SVP CLINICAL DEVELOPMENT

  • Officer
65,714 2020-07-01 0

SANOFI

  • 10% Owner
No longer subject to file 2019-07-22 0

GLAXOSMITHKLINE PLC

1,785,714 2019-07-22 0

CASDIN CAPITAL, LLC

CASDIN PARTNERS MASTER FUND, L.P.

CASDIN PARTNERS GP, LLC

CASDIN ELI

  • 10% Owner
No longer subject to file 2019-07-22 0

THIRD ROCK VENTURES IV, L.P.

THIRD ROCK VENTURES GP IV, L.P.

TRV GP IV, LLC

  • 10% Owner
2,343,154 2019-07-22 0

6 DIMENSIONS CAPITAL, L.P.

  • 10% Owner
No longer subject to file 2019-07-22 0

SECTION 32 FUND 2, LP

SECTION 32 GP 2, LLC

MARIS WILLIAM J

  • 10% Owner
No longer subject to file 2019-07-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

TOURANGEAU GREG - Officer CONTROLLER

2022-05-10 16:15:22 -0400 2022-05-06 A 6,500 a 6,500 direct

TOURANGEAU GREG - Officer CONTROLLER

2022-05-10 16:15:22 -0400 2022-05-06 A 3,250 a 16,202 direct 5.1389 5.1389 2 0.0 1

GOULD ROBERT J - Director

2022-04-11 17:00:13 -0400 2022-04-07 S 5,631 $24.02 d 506,630 direct yes -18.914 -26.6626 0.0 1 -26.6626 6

GOULD ROBERT J - Director

2022-04-11 17:00:13 -0400 2022-04-07 M 5,631 $7.84 a 512,261 direct yes -18.914 -26.6626 0.0 1 -26.6626 6

GOULD ROBERT J - Director

2022-04-11 17:00:13 -0400 2022-04-07 M 5,631 d 224,580 direct yes

GOULD ROBERT J - Director

2022-04-05 19:00:17 -0400 2022-04-05 M 52,552 $7.84 a 559,182 direct yes -0.5224 -42.1419 0.0 1 -42.1419 6

GOULD ROBERT J - Director

2022-04-05 19:00:17 -0400 2022-04-05 M 52,552 d 230,211 direct yes

GOULD ROBERT J - Director

2022-04-05 19:00:17 -0400 2022-04-05 S 52,552 $24.26 d 506,630 direct yes -0.5224 -42.1419 0.0 1 -42.1419 6

GOULD ROBERT J - Director

2022-04-05 19:00:17 -0400 2022-04-04 M 7,235 $7.84 a 513,865 direct yes -0.5224 -42.1419 0.0 1 -42.1419 6

GOULD ROBERT J - Director

2022-04-05 19:00:17 -0400 2022-04-04 M 7,235 d 282,763 direct yes

GOULD ROBERT J - Director

2022-04-05 19:00:17 -0400 2022-04-04 S 7,235 $24.02 d 506,630 direct yes -0.5224 -42.1419 0.0 1 -42.1419 6

GOULD ROBERT J - Director

2022-04-05 19:00:17 -0400 2022-04-01 M 34,464 $7.84 a 541,094 direct yes -0.5224 -42.1419 0.0 1 -42.1419 6

GOULD ROBERT J - Director

2022-04-05 19:00:17 -0400 2022-04-01 M 34,464 d 289,998 direct yes

GOULD ROBERT J - Director

2022-04-05 19:00:17 -0400 2022-04-01 S 34,464 $24.03 d 506,630 direct yes -0.5224 -42.1419 0.0 1 -42.1419 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
FULCRUM THERAPEUTICS INC FULC 2022-05-16 22:15:03 UTC 0.3291 0.4909 55000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 21:45:04 UTC 0.3291 0.4909 55000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 21:15:03 UTC 0.3291 0.4909 55000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 20:45:03 UTC 0.2739 0.5461 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 20:15:03 UTC 0.2739 0.5461 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 19:45:04 UTC 0.2739 0.5461 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 19:15:03 UTC 0.2739 0.5461 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 18:45:03 UTC 0.2739 0.5461 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 18:15:04 UTC 0.2739 0.5461 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 17:45:03 UTC 0.2739 0.5461 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 17:15:04 UTC 0.2739 0.5461 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 16:45:03 UTC 0.2714 0.5486 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 16:15:03 UTC 0.2714 0.5486 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 15:45:03 UTC 0.2714 0.5486 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 15:15:03 UTC 0.2714 0.5486 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 14:45:03 UTC 0.3902 0.4298 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 14:15:03 UTC 0.3902 0.4298 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 13:45:04 UTC 0.3902 0.4298 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 13:15:03 UTC 0.3902 0.4298 60000
FULCRUM THERAPEUTICS INC FULC 2022-05-16 12:45:04 UTC 0.3902 0.4298 60000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments